Moving towards a cranberry PACs pact

Julie Rosenborg, from Lallemand Health Ingredients, and Diana Naturals' Mathieu Besnard spoke with Shane Starling about some of the issues surrounding the proanthocyanidin content of cranberry and how the French urinary tract infection health claim passed in 2004 has influenced scientific development and the market.

They discuss how the level of 36mg of PACs specified as an efficacious dose in the French claim has been both a boon and a bane.

Differing methods of PACs measurement are also discussed and how they feed into notions of efficaciousness.

Related Topics

SuppliersAntioxidants/carotenoidsPolyphenols

Related news

Cranberry group seeks 'cran'sparency

Three European cranberry extract suppliers have formed a new association with the explicit aim of clarifying standards governing the manner in which proanthocyanidins (PACs) content is communicated to consumers.

EFSA cans cranberry health claim

The European Food Safety Authority (EFSA) has issued a negative opinion to global cranberry leader Ocean Spray for an article 14 health claim relating consumption of cranberry and urinary tract infection (UTI) in women.